These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4204467)

  • 21. [Urinary tract infection after prostate surgery. A controlled, clinical-bacteriological comparison between methenamine hippurate (Haiprex) and phenylsalicylate methenamine preparations].
    Pedersen FB; Korner B
    Ugeskr Laeger; 1977 Jun; 139(23):1350-2. PubMed ID: 327643
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prophylaxis of urinary tract infections in rats by long-term chemotherapy].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jan; 2(1):26-9. PubMed ID: 4894945
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of mandelamine in 100 unselected cases of various urinary tract infections.
    BOURQUE JP; JOYAL J
    Can Med Assoc J; 1956 Oct; 75(8):634-8. PubMed ID: 13364801
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative study of 5 anti-infective drugs in urinary infections in hospital patients].
    Bugnon A; Sakellaridès E; Schelling JL; Bonifas V
    Helv Med Acta; 1972 Apr; 36(2):246. PubMed ID: 4555108
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of clinical guidelines.
    Postgrad Med; 2001 Aug; 110(2 Suppl):16-20; discussion 26-7. PubMed ID: 19667572
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of urinary colibacillosis and tuberculous or urinary infections].
    Cibert J
    Rev Lyon Med; 1967; 16():89-92. PubMed ID: 4877849
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term prophylaxis with methenamine hippurate in girls with recurrent urinary tract infections.
    Petersen S
    Acta Paediatr Scand; 1978 Sep; 67(5):597-9. PubMed ID: 358737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
    Lagacé-Wiens PR; Nichol KA; Nicolle LE; DeCorby M; McCracken M; Mulvey MR; Zhanel GG
    J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of phosphonomycin in treatment of urinary-tract infections.
    Barnett JA; Southern PM; Luby JP; Sanford JP
    Antimicrob Agents Chemother (Bethesda); 1969; 9():349-51. PubMed ID: 4918996
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical experiences with potassium ampicillin in gynecology and obstetrics].
    Karschnia R; Granitzka S
    Fortschr Med; 1974 Feb; 92(5):205-7. PubMed ID: 4595002
    [No Abstract]   [Full Text] [Related]  

  • 31. [A new urinary tract disinfectant (mandelamine)].
    WILDE W
    Med Monatsschr; 1955 Nov; 9(11):750-3. PubMed ID: 13296825
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of urinary-tract infections with nifuradene.
    Braden B; Wilkerson R; Colmore JP
    Antimicrob Agents Chemother (Bethesda); 1967; 7():510-2. PubMed ID: 4876093
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical evaluation of Wintomylon (nalidixic acid) in the urinary tract infections].
    Yamasaki I; Kato T; Ogawa T
    Hinyokika Kiyo; 1965 Sep; 11(9):913-34. PubMed ID: 5324475
    [No Abstract]   [Full Text] [Related]  

  • 34. [Methenaminenippurate (Hiprex), an alternatice in treatment of chronic urinary tract infections].
    Udjus ED; Edman T
    Tidsskr Nor Laegeforen; 1975 Feb; 95(6):384-6. PubMed ID: 235806
    [No Abstract]   [Full Text] [Related]  

  • 35. [Methamine hippurate--an old antiseptic in a new formula].
    Wallerström BG
    Lakartidningen; 1972 Dec; 69(50):5870-3. PubMed ID: 4650469
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hexamethylene-tetramine hippurate in the treatment of urinary infections].
    Casselman J
    Acta Urol Belg; 1966 Jul; 34(3):354-8. PubMed ID: 5915552
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of minimum inhibitory concentration values for fluoroquinolones against Escherichia coli causing urinary tract infection in both hospitalized patients and outpatients.
    Tayfour M; Yuce A; Yulug N
    Saudi Med J; 2001 Oct; 22(10):848-51. PubMed ID: 11744939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro resistance of E coli to TMP/SMX and clinical failure.
    Postgrad Med; 2001 Aug; 110(2 Suppl):9-10; discussion 26-7. PubMed ID: 19667570
    [No Abstract]   [Full Text] [Related]  

  • 39. [Carbenicillin in experimental E. coli and Pseudomonas urinary tract infections].
    Prát V; Konícková L; Ritzerfeld W
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):220-2. PubMed ID: 4917427
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical evaluation of cephalexin in urinary tract infection.
    Kawamura J
    Postgrad Med J; 1970 Oct; ():Suppl:28-30. PubMed ID: 4922708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.